Is this you? Create Your Porfile
Avatar

Fabio Paleari

Boehringer Ingelheim

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Fabio Paleari is active.

Explore More

Publication

Featured researches published by Fabio Paleari.

Archive | 2005

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Stephan Georg Mueller; Klaus Rudolf; Philipp Lustenberger; Dirk Stenkamp; Alexander Dreyer; Kirsten Arndt; Henri Doods; Gerhard Schaenzle; Marco Santagostino; Fabio Paleari

Archive | 2005

Selected cgrp antagonists, methods for the production thereof and their use as medicaments

Stephan Georg Mueller; Klaus Rudolf; Philipp Lustenberger; Dirk Stenkamp; Alexander Dreyer; Kirsten Arndt; Henri Doods; Gerhard Schaenzle; Marco Santagostino; Fabio Paleari

Archive | 2006

Cgrp antagonists, method for the production thereof, and their use as medicaments

Stephan Georg Mueller; Klaus Rudolf; Philipp Lustenberger; Dirk Stenkamp; Marco Santagostino; Fabio Paleari; Henri Doods; Kirsten Arndt; Gerhard Schaenzle

Archive | 2006

2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists

Stephan Georg Mueller; Klaus Rudolf; Philipp Lustenberger; Dirk Stenkamp; Marco Santagostino; Fabio Paleari; Alexander Dreyer; Kirsten Arndt; Henri Doods; Gerhard Schaenzle

Archive | 2009

CGRP antagonists, method for production thereof, and their use as medicaments

Georg Mueller Stephan; Philipp Lustenberger; Marco Santagostino; Henri Doods; Gerhard Schaenzle; Klaus Rudolf; Dirk Stenkamp; Fabio Paleari; Kirsten Arndt

Archive | 2007

2-okso-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidiner anvendt som cgrp-antagonister

Georg Mueller Stephan; Klaus Rudolf; Philipp Lustenberger; Dirk Stenkamp; Marco Santagostino; Fabio Paleari; Henri Doods; Kirsten Arndt; Gerhard Schaenzle; Alexander Dreyer

Archive | 2006

CGRP antagonists, their preparation and use as a medicament

Stephan Georg Mueller; Klaus Rudlof; Philipp Lustenberger; Dirk Stenkamp; Marco Santagostino; Fabio Paleari; Alexander Dreyer; Kirsten Arndt; Henri Doods; Gerhard Schaenzle

Archive | 2006

2-oxo-1,2,4,5-tetrahydro-1,3-benzdiazepin-3-yl-piperidine als cgrp-antagonisten

Stephan Georg Mueller; Klaus Rudolf; Philipp Lustenberger; Dirk Stenkamp; Marco Santagostino; Fabio Paleari; Alexander Dreyer; Kirsten Arndt; Henri Doods; Gerhard Schaenzle

Archive | 2006

CGRP-ANTAGONISTS, PROCESS FOR THEIR PREPARATION AS WELL AS THEIR USE AS MEDICAMENTS

Stephan Georg Mueller; Klaus Rudolf; Philipp Lustenberger; Dirk Stenkamp; Marco Santagostino; Fabio Paleari; Henri Doods; Kirsten Arndt; Gerhard Schaenzle

Archive | 2006

Antagonistes cgrp, procede de production associe et leur utilisation en tant que medicaments

Stephan Georg Mueller; Klaus Rudolf; Philipp Lustenberger; Dirk Stenkamp; Marco Santagostino; Fabio Paleari; Henri Doods; Kirsten Arndt; Gerhard Schaenzle

Explore More

Collaboration

Dive into the Fabio Paleari's collaboration.

Top Co-Authors
Avatar

Gerhard Schaenzle

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Henri Doods

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Kirsten Arndt

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Marco Santagostino

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Philipp Lustenberger

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Klaus Rudolf

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Stephan Georg Mueller

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Dirk Stenkamp

University of Marburg

View shared research outputs
Top Co-Authors
Avatar

Alexander Dreyer

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Dirk Stenkamp

University of Marburg

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge